Seeking Alpha

Seeking Alpha Portfolio App for iPad

190 people get IGXT.OB articles and Market Currents by email alert.

Get email alerts on IGXT.OB »

IGXT.OB

IntelGenx Technologies Corp.

5/25/2013, 5:20 PM ET

Quote & Headlines Market Currents StockTalk

igxt chart

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

190 people get IGXT.OB articles and Market Currents by email alert.

Get email alerts on IGXT.OB »

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe • Tue, Feb 5 • 4 Comments
IntelGenx Striving To Create A Second Biovail
Len Zehr • Tue, Jul 10, 2012 • 14 Comments
A Bio-Pharma Buy And Sell List: Part 2
Scott Matusow • Wed, Jan 18, 2012 • 71 Comments
A Bio-Pharma Buy And Sell List: Part 1
Scott Matusow • Wed, Jan 18, 2012 • 11 Comments
5 Pharma Companies With November Catalysts
Spencer Knight • Tue, Nov 1, 2011 • 2 Comments
Upcoming FDA Approval Decision Dates for Q4 2011 - How You Can Profit
David Zanoni • Thu, Oct 6, 2011 • 9 Comments
4 Biotech Sleepers With Over 100% Upside
Epsilon • Mon, Aug 1, 2011 • 13 Comments
BioMed News Bytes: IntelGenx, Pressure BioSciences
Mike Havrilla • Thu, Oct 15, 2009
FDA Extreme Trades: 16 Stocks Under 5 Bucks
Mike Havrilla • Sun, Jun 28, 2009 • 10 Comments

To learn more about Seeking Alpha Pro, click here.

IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe • Tue, Feb 5 • 4 Comments
IntelGenx Striving To Create A Second Biovail
Len Zehr • Tue, Jul 10, 2012 • 14 Comments

A Bio-Pharma Buy And Sell List: Part 2
Scott Matusow • Wed, Jan 18, 2012 • 71 Comments
A Bio-Pharma Buy And Sell List: Part 1
Scott Matusow • Wed, Jan 18, 2012 • 11 Comments
5 Pharma Companies With November Catalysts
Spencer Knight • Tue, Nov 1, 2011 • 2 Comments
Upcoming FDA Approval Decision Dates for Q4 2011 - How You Can Profit
David Zanoni • Thu, Oct 6, 2011 • 9 Comments
4 Biotech Sleepers With Over 100% Upside
Epsilon • Mon, Aug 1, 2011 • 13 Comments
BioMed News Bytes: IntelGenx, Pressure BioSciences
Mike Havrilla • Thu, Oct 15, 2009
FDA Extreme Trades: 16 Stocks Under 5 Bucks
Mike Havrilla • Sun, Jun 28, 2009 • 10 Comments

There are no Transcripts on IGXT.OB.

There are no News articles on IGXT.OB.

IGXT.OB vs. ETF Alternatives

Company Description

Currently, there's no company description for IGXT.OB.

Sector: Services

Industry: Research Services

Country: United States

0123456789
IGXT.OB: http://bit.ly/GKrnRe
3/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

reachmygoals1
FDA approval last November. IGXT.OB is worth a look again, deeply undervalued at 0.50
2/29/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

reachmygoals1
PPS has dropped with market on IGXT.OB It has bottomed, climbing up the stairs to $1.00 A few big catalysts this quarter.
8/14/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Check out: http://seekingalpha.com/a/62vb IGXT.OB is risky, but has a lot of promise. Technical buy.
8/1/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

reachmygoals1
IGXT.OB has a 10 drug pipeline.Antidepressant drug submitted to FDA for NDA acceptance-2H 2011, FDA decision for approval.Ready to run soon.
5/22/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES